Related Experiment Videos

Endomyocardial biopsy in infants and children with cardiomyopathy

R Narayan1, S Menahem, C W Chow

  • 1Department of Cardiology, Royal Children's Hospital, Parkville, Victoria, Australia.

Clinical Cardiology
|November 1, 1991
PubMed

Insights

Endomyocardial biopsy in children with cardiomyopathy can diagnose rare conditions like hemochromatosis and myocarditis. While risky, this procedure offers valuable diagnostic and prognostic insights for serious heart disorders.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Pathology

Background:

  • Cardiomyopathy in infants and children presents diagnostic challenges.
  • Endomyocardial biopsy (EMB) is an invasive procedure with potential diagnostic yield.

Purpose of the Study:

  • To evaluate the diagnostic utility and safety of EMB in pediatric cardiomyopathy.
  • To assess the impact of EMB on diagnosis, treatment, and prognosis.

Main Methods:

  • Retrospective review of 21 symptomatic infants and children undergoing EMB.
  • Analysis of clinical presentation, biopsy findings, and patient outcomes.

Main Results:

  • Diagnoses included hemochromatosis, Adriamycin cardiomyopathy, lymphocytic myocarditis, endocardial fibroelastosis, endomyocardial fibrosis, and mitochondrial abnormalities.
  • 11 patients had normal or nonspecific findings.
  • Two cases of myocardial perforation occurred, with successful resuscitation.

Conclusions:

  • EMB can provide crucial diagnostic information in selected pediatric cardiomyopathy cases.
  • Despite risks and a low positive yield, EMB may be indicated for serious cardiac conditions.
  • Findings can guide treatment and offer prognostic value in pediatric heart disease.

Related Concept Videos